Charles River Laboratories International

CRL11 Dec 2024
Healthcare
$202.72
-0.02 (-2.33%)
Lowest Today
$196.5
Highest Today
$202.72
Today’s Open
$202.72
Prev. Close
$201.75
52 Week High
$275
52 Week Low
$176.48
To Invest in Charles River Laboratories International

Charles River Laboratories International

Healthcare
CRL11 Dec 2024
-0.02 (-2.33%)
1M
3M
6M
1Y
5Y
Low
$196.5
Day’s Range
High
$202.72
196.5
52 Week Low
$176.48
52-Week Range
52 Week High
$275
176.48
1 Day
-
1 Week
-1.3%
1 month return
-10.88%
3 month return
+1.52%
6 month return
-6.53%
1 Year return
-4.72%
3 Years return
-45.51%
5 Years return
+34.4%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
11.93
BlackRock Inc
9.95
Wellington Management Company LLP
7.32
State Street Corp
4.17
Kayne Anderson Rudnick Investment Management LLC
3.79
Vanguard Health Care Inv
3.66
Allspring Global Investments Holdings, LLC
3.44

Market Status

Fundamentals
Market Cap
10316.73 mln
PB Ratio
2.59
PE Ratio
25.16
Enterprise Value
12357.75 mln
Total Assets
8195 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Organisation
Charles River Laboratories International
Employees
20400
Industry
Diagnostics & Research
CEO
Mr. James C. Foster J.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step